[Acceptance of digital apps in the follow-up of patients with head and neck tumors].
Akzeptanz digitaler Apps in der Nachsorge von Patient*innen mit Kopf-Hals-Tumoren.
Data collection
Human papilloma virus
Patient-reported outcome measures
Quality of life
Questionnaire
Journal
HNO
ISSN: 1433-0458
Titre abrégé: HNO
Pays: Germany
ID NLM: 2985099R
Informations de publication
Date de publication:
03 May 2024
03 May 2024
Historique:
accepted:
09
02
2024
medline:
3
5
2024
pubmed:
3
5
2024
entrez:
3
5
2024
Statut:
aheadofprint
Résumé
Patient-reported outcome (PRO) measures lead to improved quality of life in cancer patients and possibly to earlier detection of tumor recurrence. Patient interest in complementing tumor follow-up care with apps for recording PROs was assessed using a questionnaire. An independently created questionnaire to record the interest of tumor patients in a digitalized form of tumor follow-up care was evaluated (n = 110). In the study, the majority of tumor patients were interested in using an app for tumor disease. Taking age into account, the number increased even further for patients < 60 years of age, as expected. In line with this, human papillomavirus (HPV)-positive patients showed significantly greater interest (p = 0.021). The introduction of an app is supported by the majority of tumor patients. In addition to recording PROs, other applications (appointment reminders, patient files, sports/nutrition programs) could also be integrated. HINTERGRUND: „Patient-reported outcome measures“ führen bei Tumorpatient*innen sowohl zu einer verbesserten Lebensqualität als auch möglicherweise zu einer früheren Erkennung von Tumorrezidiven. Erfragt wurde das Interesse der Patient*innen an einer Ergänzung der Tumornachsorge durch Apps zur Erfassung der Lebensqualität (patient-reported outcome [PRO]). Dazu erfolgte die Auswertung eines selbstständig erstellten Fragebogens zur Erfassung des Interesses von Tumorpatient*innen an einer digitalisierten Form der Tumornachsorge (n = 110) ERGEBNISSE: In der Studie zeigten sich Tumorpatient*innen zum Großteil interessiert an einer App-Nutzung zur Tumorerkrankung. Unter Einbeziehung des Alters stieg die Anzahl erwartungsgemäß bei Patient*innen < 60 Jahren noch weiter. Dazu passend zeigten für humanes Papillomavirus (HPV-)positive Patient*innen ein signifikant größeres Interesse (p = 0,021). Die Einführung einer App wird vom Großteil der Tumorpatient*innen befürwortet. Neben der Erfassung des PRO könnten hier weitere Anwendungen (Terminerinnerung, Patientenakte, Sport‑/Ernährungsprogramme) integriert werden.
Sections du résumé
BACKGROUND
BACKGROUND
Patient-reported outcome (PRO) measures lead to improved quality of life in cancer patients and possibly to earlier detection of tumor recurrence.
OBJECTIVE
OBJECTIVE
Patient interest in complementing tumor follow-up care with apps for recording PROs was assessed using a questionnaire.
MATERIALS AND METHODS
METHODS
An independently created questionnaire to record the interest of tumor patients in a digitalized form of tumor follow-up care was evaluated (n = 110).
RESULTS
RESULTS
In the study, the majority of tumor patients were interested in using an app for tumor disease. Taking age into account, the number increased even further for patients < 60 years of age, as expected. In line with this, human papillomavirus (HPV)-positive patients showed significantly greater interest (p = 0.021).
CONCLUSION
CONCLUSIONS
The introduction of an app is supported by the majority of tumor patients. In addition to recording PROs, other applications (appointment reminders, patient files, sports/nutrition programs) could also be integrated.
ZUSAMMENFASSUNG
UNASSIGNED
HINTERGRUND: „Patient-reported outcome measures“ führen bei Tumorpatient*innen sowohl zu einer verbesserten Lebensqualität als auch möglicherweise zu einer früheren Erkennung von Tumorrezidiven.
FRAGESTELLUNG
UNASSIGNED
Erfragt wurde das Interesse der Patient*innen an einer Ergänzung der Tumornachsorge durch Apps zur Erfassung der Lebensqualität (patient-reported outcome [PRO]).
MATERIAL UND METHODE
UNASSIGNED
Dazu erfolgte die Auswertung eines selbstständig erstellten Fragebogens zur Erfassung des Interesses von Tumorpatient*innen an einer digitalisierten Form der Tumornachsorge (n = 110) ERGEBNISSE: In der Studie zeigten sich Tumorpatient*innen zum Großteil interessiert an einer App-Nutzung zur Tumorerkrankung. Unter Einbeziehung des Alters stieg die Anzahl erwartungsgemäß bei Patient*innen < 60 Jahren noch weiter. Dazu passend zeigten für humanes Papillomavirus (HPV-)positive Patient*innen ein signifikant größeres Interesse (p = 0,021).
SCHLUSSFOLGERUNG
UNASSIGNED
Die Einführung einer App wird vom Großteil der Tumorpatient*innen befürwortet. Neben der Erfassung des PRO könnten hier weitere Anwendungen (Terminerinnerung, Patientenakte, Sport‑/Ernährungsprogramme) integriert werden.
Autres résumés
Type: Publisher
(ger)
HINTERGRUND: „Patient-reported outcome measures“ führen bei Tumorpatient*innen sowohl zu einer verbesserten Lebensqualität als auch möglicherweise zu einer früheren Erkennung von Tumorrezidiven.
Identifiants
pubmed: 38700582
doi: 10.1007/s00106-024-01463-6
pii: 10.1007/s00106-024-01463-6
doi:
Types de publication
English Abstract
Journal Article
Langues
ger
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Szturz P, Van Laer C, Simon C, Van Gestel D, Bourhis J, Vermorken JB (2020) Follow-up of head and neck cancer survivors: tipping the balance of intensity. Front Oncol 10:688. https://doi.org/10.3389/fonc.2020.00688
doi: 10.3389/fonc.2020.00688
pubmed: 32435619
pmcid: 7218054
Cooper JS et al (2012) Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 84(5):1198–1205. https://doi.org/10.1016/j.ijrobp.2012.05.008
doi: 10.1016/j.ijrobp.2012.05.008
pubmed: 22749632
pmcid: 3465463
Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy—Langendijk—2005—Cancer—Wiley Online Library. https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.21340 . Zugegriffen: 10. Nov. 2023
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR (2020) Head and neck squamous cell carcinoma. Nat Rev Dis Primer 6(1):92. https://doi.org/10.1038/s41572-020-00224-3
doi: 10.1038/s41572-020-00224-3
Grégoire V, Lefebvre J‑L, Licitra L, Felip E (2010) Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21:v184–v186. https://doi.org/10.1093/annonc/mdq185
doi: 10.1093/annonc/mdq185
pubmed: 20555077
Backes C, Bier H, Knopf A (2017) Therapeutic implications of tumor free margins in head and neck squamous cell carcinoma. Oncotarget 8(48):84320–84328. https://doi.org/10.18632/oncotarget.21035
doi: 10.18632/oncotarget.21035
pubmed: 29137426
pmcid: 5663598
Langer T (2019) S3-Leitlinie Larynxkarzinom
“Radiotherapy for T1-2N0 glottic cancer: a multivariate analysis of predictive factors for the long-term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients—Al-Mamgani—2013—Clinical Otolaryngology—Wiley Online Library.” Accessed: Nov. 10, 2023. [Online]. Available: https://onlinelibrary.wiley.com/doi/10.1111/coa.12139
“Prognostic value of continued smoking on survival and recurrence rates in patients with head and neck cancer: A systematic review—van Imhoff—2016—Head & Neck—Wiley Online Library.” Accessed: Nov. 10, 2023. [Online]. Available: https://onlinelibrary.wiley.com/doi/10.1002/hed.24082
Agrawal A, Hammond TH, Young GS, Avon AL, Ozer E, Schuller DE (2009) Factors affecting long-term survival in patients with recurrent head and neck cancer may help define the role of post-treatment surveillance. Laryngoscope 119(11):2135–2140. https://doi.org/10.1002/lary.20527
doi: 10.1002/lary.20527
pubmed: 19507214
de Visscher AVM, Manni JJ (1994) Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity: does it make sense? Arch Otolaryngol Head Neck Surg 120(9):934–939. https://doi.org/10.1001/archotol.1994.01880330022005
doi: 10.1001/archotol.1994.01880330022005
pubmed: 8074820
List MA et al (2000) How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment? J Clin Oncol 18(4):877–884. https://doi.org/10.1200/JCO.2000.18.4.877
doi: 10.1200/JCO.2000.18.4.877
pubmed: 10673531
Böhm F et al (2022) Onkologische Nachsorge von Kopf-Hals-Tumor-Patienten. HNO 70(4):317–330. https://doi.org/10.1007/s00106-022-01154-0
doi: 10.1007/s00106-022-01154-0
pubmed: 35298668
Machtay M et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26(21):3582–3589. https://doi.org/10.1200/JCO.2007.14.8841
doi: 10.1200/JCO.2007.14.8841
pubmed: 18559875
pmcid: 4911537
Calvert M, Kyte D, Price G, Valderas JM, Hjollund NH (2019) Maximising the impact of patient reported outcome assessment for patients and society. BMJ 364:k5267. https://doi.org/10.1136/bmj.k5267
doi: 10.1136/bmj.k5267
pubmed: 30679170
Jensen RE et al (2014) Review of electronic patient-reported outcomes systems used in cancer clinical care. J Oncol Pract 10(4):e215–e222. https://doi.org/10.1200/JOP.2013.001067
doi: 10.1200/JOP.2013.001067
pubmed: 24301843
Basch E et al (2017) Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA 318(2):197–198. https://doi.org/10.1001/jama.2017.7156
doi: 10.1001/jama.2017.7156
pubmed: 28586821
pmcid: 5817466
Zebralla V et al (2023) Digitale Patient-Reported Outcome Measures in der Nachsorge von Kopf-Hals-Tumoren. Onkologie 29:38–44. https://doi.org/10.1007/s00761-022-01275-9
doi: 10.1007/s00761-022-01275-9
Wald T et al (2022) Web-based patient-reported outcomes for ENT patients—evaluation of the status quo, patients’ view, and future perspectives. Int J Environ Res Public Health 19(18):11773. https://doi.org/10.3390/ijerph191811773
doi: 10.3390/ijerph191811773
pubmed: 36142048
pmcid: 9517261